• Explore /
  • Poster
  • / Efficacy and safety of rucaparib maintenance treatment in patients from ARIEL3 with platinum-sensitive, recurrent ovarian carcinoma not associated with homologous recombination deficiency.

Efficacy and safety of rucaparib maintenance treatment in patients from ARIEL3 with platinum-sensitive, recurrent ovarian carcinoma not associated with homologous recombination deficiency.

Abstract Poster

Authors

Robert Coleman

Robert L. Coleman

U.S. Oncology Research, The Woodlands, TX

Robert L. Coleman , Amit M. Oza , Domenica Lorusso , Carol Aghajanian , Ana Oaknin , Andrew Dean , Nicoletta Colombo , Johanne I Weberpals , Andrew R. Clamp , Giovanni Scambia , Alexandra Leary , Robert W. Holloway , Margarita Amenedo Gancedo , Peter C.C. Fong , Jeffrey C. Goh , David M. O'Malley , Sandra M. Goble , Lara Maloney , Jonathan A. Ledermann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

Clinicaltrials.gov

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5544)

DOI

10.1200/JCO.2022.40.16_suppl.5544

Abstract #

5544

Poster Bd #

423

Abstract Disclosures

Similar Posters

First Author: Bradley Corr

First Author: Robert L. Coleman

First Author: Ecaterina Elena Dumbrava

First Author: Ana Oaknin